Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Alabama by County

Non-Hodgkin Lymphoma (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Alabama6


US (SEER+NPCR)1


Autauga County6


Baldwin County6


Barbour County6


Blount County6


Calhoun County6


Chambers County6


Chilton County6


Coffee County6


Colbert County6


Covington County6


Cullman County6


Dale County6


Dallas County6


DeKalb County6


Elmore County6


Escambia County6


Etowah County6


Geneva County6


Houston County6


Jackson County6


Jefferson County6


Lauderdale County6


Lawrence County6


Lee County6


Limestone County6


Madison County6


Marion County6


Marshall County6


Mobile County6


Montgomery County6


Morgan County6


Pike County6


Randolph County6


Russell County6


Shelby County6


St. Clair County6


Talladega County6


Tallapoosa County6


Tuscaloosa County6


Walker County6


Winston County6


Bibb County6 Bullock County6 Butler County6 Cherokee County6 Choctaw County6 Clarke County6 Clay County6 Cleburne County6 Conecuh County6 Coosa County6 Crenshaw County6 Fayette County6 Franklin County6 Greene County6 Hale County6 Henry County6 Lamar County6 Lowndes County6 Macon County6 Marengo County6 Monroe County6 Perry County6 Pickens County6 Sumter County6 Washington County6 Wilcox County6

Notes:
Created by statecancerprofiles.cancer.gov on 10/12/2024 11:38 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Φ Rural-Urban Continuum Codes provided by the USDA.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.